1 mg each: Draw 20 units (0.2 mL)
Jastreboff AM, Kaplan LM, Frias JP, Wu Q, Du Y, Gurbuz S, et al
These drugs are intended to help regulate blood sugar levels and promote weight loss by mimicking the effects of the GLP-1 hormone, which stimulates insulin production and slows down digestion
*Unfortunately, not everyone will be a good candidate for Semaglutide
Because the risk of gastroparesis is common to the entire class of drugs, any published literature regarding the association between gastroparesis and any GLP-1RA (such as tirzepatide, exenatide, liraglutide, albiglutide, dulaglutide, lixisenatide, and semaglutide) should have put Defendant on notice of the need to warn patients and prescribing physicians of the risk of gastroparesis associated with these drugs Defendant knew or should have known of this risk of gastroparesis from the clinical trials, medical literature, and case reports. Cynthia L